Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Clinical trial NCT00606645 · COMPLETED

Trial details

NCT number: NCT00606645
Sponsor: Xencor, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Lymphoma Anaplastic Large Cell Lymphoma

Start date: 2007-12-01
Primary completion: 2010-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.